Accuracy of Colon Capsule Endoscopy for Colorectal Neoplasia Detection in Individuals Referred for a Screening Colonoscopy

Backround. Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. Aim. To assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC). Methods. From 2011–2015, we perfo...

Full description

Saved in:
Bibliographic Details
Published inGastroenterology research and practice Vol. 2019; no. 2019; pp. 1 - 8
Main Authors Drastich, Pavel, Spicak, Julius, Buckova, Barbora, Ngo, Ondrej, Suchanek, Stepan, Vojtechova, Gabriela, Benes, Marek, Tachecí, Ilja, Martinek, Jan, Majek, Ondrej, Grega, Tomas, Zavoral, Miroslav, Voska, Michal, Bures, Jan
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Publishing Corporation 2019
Hindawi
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text
ISSN1687-6121
1687-630X
DOI10.1155/2019/5975438

Cover

Abstract Backround. Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. Aim. To assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC). Methods. From 2011–2015, we performed a multicenter, prospective, cross-over study evaluating the use of CCE2 as a possible colorectal cancer (CRC) screening test based on the assessment of the method’s characteristics (accuracy) and safety and patient acceptance of the routine. Enrolled participants fulfilled the CRC screening population criteria if they were asymptomatic, were older than 50, and had no personal or familial history of colorectal neoplasia. The primary outcome was accuracy for the detection of polyps≥6 mm. Secondary outcomes were accuracy for all polyps, polyps≥10 mm, adenomas≥10 mm, and cancers, the quality of bowel cleansing, safety, and CCE2 acceptability by the screening population. Results. A total of 236 individuals were examined; 11 patients (5%) were excluded. Therefore, 225 subjects (95%) were considered in the intention-to-screen (ITS) group. A total of 201 patients (89%) completed both examinations successfully (per protocol group). In the ITS group, polyps were diagnosed during CC in 114 subjects (51%); polyps≥6 mm, polyps≥10 mm, and adenomas≥10 mm were diagnosed in 34 (15%), 16 (7%), and 11 (5%) patients, respectively. The sensitivity of CCE2 for polyps≥6 mm, polyps≥10 mm, and adenomas≥10 mm was 79% (95% confidence interval (CI): 62–91%), 88% (95% CI: 62–98%), and 100% (95% CI: 72–100%), respectively. Conclusion. Second-generation capsule colonoscopy is a safe, noninvasive, and sensitive method for colorectal neoplasia detection although CC remains the preferred method for considerable proportion of subjects. CCE2 may therefore be accepted as the primary screening test for colorectal cancer screening.
AbstractList Backround. Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. Aim. To assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC). Methods. From 2011–2015, we performed a multicenter, prospective, cross-over study evaluating the use of CCE2 as a possible colorectal cancer (CRC) screening test based on the assessment of the method’s characteristics (accuracy) and safety and patient acceptance of the routine. Enrolled participants fulfilled the CRC screening population criteria if they were asymptomatic, were older than 50, and had no personal or familial history of colorectal neoplasia. The primary outcome was accuracy for the detection of polyps≥6 mm. Secondary outcomes were accuracy for all polyps, polyps≥10 mm, adenomas≥10 mm, and cancers, the quality of bowel cleansing, safety, and CCE2 acceptability by the screening population. Results. A total of 236 individuals were examined; 11 patients (5%) were excluded. Therefore, 225 subjects (95%) were considered in the intention-to-screen (ITS) group. A total of 201 patients (89%) completed both examinations successfully (per protocol group). In the ITS group, polyps were diagnosed during CC in 114 subjects (51%); polyps≥6 mm, polyps≥10 mm, and adenomas≥10 mm were diagnosed in 34 (15%), 16 (7%), and 11 (5%) patients, respectively. The sensitivity of CCE2 for polyps≥6 mm, polyps≥10 mm, and adenomas≥10 mm was 79% (95% confidence interval (CI): 62–91%), 88% (95% CI: 62–98%), and 100% (95% CI: 72–100%), respectively. Conclusion. Second-generation capsule colonoscopy is a safe, noninvasive, and sensitive method for colorectal neoplasia detection although CC remains the preferred method for considerable proportion of subjects. CCE2 may therefore be accepted as the primary screening test for colorectal cancer screening.
Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. To assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC). From 2011-2015, we performed a multicenter, prospective, cross-over study evaluating the use of CCE2 as a possible colorectal cancer (CRC) screening test based on the assessment of the method's characteristics (accuracy) and safety and patient acceptance of the routine. Enrolled participants fulfilled the CRC screening population criteria if they were asymptomatic, were older than 50, and had no personal or familial history of colorectal neoplasia. The primary outcome was accuracy for the detection of polyps ≥ 6 mm. Secondary outcomes were accuracy for all polyps, polyps ≥ 10 mm, adenomas ≥ 10 mm, and cancers, the quality of bowel cleansing, safety, and CCE2 acceptability by the screening population. A total of 236 individuals were examined; 11 patients (5%) were excluded. Therefore, 225 subjects (95%) were considered in the intention-to-screen (ITS) group. A total of 201 patients (89%) completed both examinations successfully (per protocol group). In the ITS group, polyps were diagnosed during CC in 114 subjects (51%); polyps ≥ 6 mm, polyps ≥ 10 mm, and adenomas ≥ 10 mm were diagnosed in 34 (15%), 16 (7%), and 11 (5%) patients, respectively. The sensitivity of CCE2 for polyps ≥ 6 mm, polyps ≥ 10 mm, and adenomas ≥ 10 mm was 79% (95% confidence interval (CI): 62-91%), 88% (95% CI: 62-98%), and 100% (95% CI: 72-100%), respectively. Second-generation capsule colonoscopy is a safe, noninvasive, and sensitive method for colorectal neoplasia detection although CC remains the preferred method for considerable proportion of subjects. CCE2 may therefore be accepted as the primary screening test for colorectal cancer screening.
Backround. Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. Aim. To assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC). Methods. From 2011-2015, we performed a multicenter, prospective, cross-over study evaluating the use of CCE2 as a possible colorectal cancer (CRC) screening test based on the assessment of the method's characteristics (accuracy) and safety and patient acceptance of the routine. Enrolled participants fulfilled the CRC screening population criteria if they were asymptomatic, were older than 50, and had no personal or familial history of colorectal neoplasia. The primary outcome was accuracy for the detection of polyps > 6 mm. Secondary outcomes were accuracy for all polyps, polyps > 10 mm, adenomas [greater than or equal to] 10 mm, and cancers, the quality of bowel cleansing, safety, and CCE2 acceptability by the screening population. Results. A total of 236 individuals were examined; 11 patients (5%) were excluded. Therefore, 225 subjects (95%) were considered in the intention-to-screen (ITS) group. A total of 201 patients (89%) completed both examinations successfully (per protocol group). In the ITS group, polyps were diagnosed during CC in 114 subjects (51%); polyps > 6 mm, polyps > 10 mm, and adenomas > 10 mm were diagnosed in 34 (15%), 16 (7%), and 11 (5%) patients, respectively. The sensitivity of CCE2 for polyps > 6 mm, polyps > 10 mm, and adenomas > 10 mm was 79% (95% confidence interval (CI): 62-91%), 88% (95% CI: 62-98%), and 100% (95% CI: 72-100%), respectively. Conclusion. Second-generation capsule colonoscopy is a safe, noninvasive, and sensitive method for colorectal neoplasia detection although CC remains the preferred method for considerable proportion of subjects. CCE2 may therefore be accepted as the primary screening test for colorectal cancer screening.
Backround . Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. Aim . To assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC). Methods . From 2011–2015, we performed a multicenter, prospective, cross-over study evaluating the use of CCE2 as a possible colorectal cancer (CRC) screening test based on the assessment of the method’s characteristics (accuracy) and safety and patient acceptance of the routine. Enrolled participants fulfilled the CRC screening population criteria if they were asymptomatic, were older than 50, and had no personal or familial history of colorectal neoplasia. The primary outcome was accuracy for the detection of polyps ≥ 6   mm . Secondary outcomes were accuracy for all polyps, polyps ≥ 10   mm , adenomas ≥ 10   mm , and cancers, the quality of bowel cleansing, safety, and CCE2 acceptability by the screening population. Results . A total of 236 individuals were examined; 11 patients (5%) were excluded. Therefore, 225 subjects (95%) were considered in the intention-to-screen (ITS) group. A total of 201 patients (89%) completed both examinations successfully (per protocol group). In the ITS group, polyps were diagnosed during CC in 114 subjects (51%); polyps ≥ 6   mm , polyps ≥ 10   mm , and adenomas ≥ 10   mm were diagnosed in 34 (15%), 16 (7%), and 11 (5%) patients, respectively. The sensitivity of CCE2 for polyps ≥ 6   mm , polyps ≥ 10   mm , and adenomas ≥ 10   mm was 79% (95% confidence interval (CI): 62–91%), 88% (95% CI: 62–98%), and 100% (95% CI: 72–100%), respectively. Conclusion . Second-generation capsule colonoscopy is a safe, noninvasive, and sensitive method for colorectal neoplasia detection although CC remains the preferred method for considerable proportion of subjects. CCE2 may therefore be accepted as the primary screening test for colorectal cancer screening.
Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening.BACKROUNDCapsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening.To assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC).AIMTo assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC).From 2011-2015, we performed a multicenter, prospective, cross-over study evaluating the use of CCE2 as a possible colorectal cancer (CRC) screening test based on the assessment of the method's characteristics (accuracy) and safety and patient acceptance of the routine. Enrolled participants fulfilled the CRC screening population criteria if they were asymptomatic, were older than 50, and had no personal or familial history of colorectal neoplasia. The primary outcome was accuracy for the detection of polyps ≥ 6 mm. Secondary outcomes were accuracy for all polyps, polyps ≥ 10 mm, adenomas ≥ 10 mm, and cancers, the quality of bowel cleansing, safety, and CCE2 acceptability by the screening population.METHODSFrom 2011-2015, we performed a multicenter, prospective, cross-over study evaluating the use of CCE2 as a possible colorectal cancer (CRC) screening test based on the assessment of the method's characteristics (accuracy) and safety and patient acceptance of the routine. Enrolled participants fulfilled the CRC screening population criteria if they were asymptomatic, were older than 50, and had no personal or familial history of colorectal neoplasia. The primary outcome was accuracy for the detection of polyps ≥ 6 mm. Secondary outcomes were accuracy for all polyps, polyps ≥ 10 mm, adenomas ≥ 10 mm, and cancers, the quality of bowel cleansing, safety, and CCE2 acceptability by the screening population.A total of 236 individuals were examined; 11 patients (5%) were excluded. Therefore, 225 subjects (95%) were considered in the intention-to-screen (ITS) group. A total of 201 patients (89%) completed both examinations successfully (per protocol group). In the ITS group, polyps were diagnosed during CC in 114 subjects (51%); polyps ≥ 6 mm, polyps ≥ 10 mm, and adenomas ≥ 10 mm were diagnosed in 34 (15%), 16 (7%), and 11 (5%) patients, respectively. The sensitivity of CCE2 for polyps ≥ 6 mm, polyps ≥ 10 mm, and adenomas ≥ 10 mm was 79% (95% confidence interval (CI): 62-91%), 88% (95% CI: 62-98%), and 100% (95% CI: 72-100%), respectively.RESULTSA total of 236 individuals were examined; 11 patients (5%) were excluded. Therefore, 225 subjects (95%) were considered in the intention-to-screen (ITS) group. A total of 201 patients (89%) completed both examinations successfully (per protocol group). In the ITS group, polyps were diagnosed during CC in 114 subjects (51%); polyps ≥ 6 mm, polyps ≥ 10 mm, and adenomas ≥ 10 mm were diagnosed in 34 (15%), 16 (7%), and 11 (5%) patients, respectively. The sensitivity of CCE2 for polyps ≥ 6 mm, polyps ≥ 10 mm, and adenomas ≥ 10 mm was 79% (95% confidence interval (CI): 62-91%), 88% (95% CI: 62-98%), and 100% (95% CI: 72-100%), respectively.Second-generation capsule colonoscopy is a safe, noninvasive, and sensitive method for colorectal neoplasia detection although CC remains the preferred method for considerable proportion of subjects. CCE2 may therefore be accepted as the primary screening test for colorectal cancer screening.CONCLUSIONSecond-generation capsule colonoscopy is a safe, noninvasive, and sensitive method for colorectal neoplasia detection although CC remains the preferred method for considerable proportion of subjects. CCE2 may therefore be accepted as the primary screening test for colorectal cancer screening.
Audience Academic
Author Benes, Marek
Tachecí, Ilja
Spicak, Julius
Majek, Ondrej
Zavoral, Miroslav
Vojtechova, Gabriela
Drastich, Pavel
Suchanek, Stepan
Grega, Tomas
Voska, Michal
Ngo, Ondrej
Buckova, Barbora
Martinek, Jan
Bures, Jan
AuthorAffiliation 7 GEP Clinic, Prague, CZ 130 00, Czech Republic
4 Charles University in Prague, Institute of Physiology, Czech Republic
1 Department of Medicine, First Faculty of Medicine, Charles University, Military University Hospital, Prague, CZ 169 02, Czech Republic
6 2nd Department of Internal Medicine-Gastroenterology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, CZ 500 05, Czech Republic
3 Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, CZ 140 21, Czech Republic
5 University of Ostrava, Medical Faculty, Czech Republic
2 Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, CZ 625 00, Czech Republic
AuthorAffiliation_xml – name: 2 Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, CZ 625 00, Czech Republic
– name: 6 2nd Department of Internal Medicine-Gastroenterology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, CZ 500 05, Czech Republic
– name: 1 Department of Medicine, First Faculty of Medicine, Charles University, Military University Hospital, Prague, CZ 169 02, Czech Republic
– name: 3 Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, CZ 140 21, Czech Republic
– name: 4 Charles University in Prague, Institute of Physiology, Czech Republic
– name: 5 University of Ostrava, Medical Faculty, Czech Republic
– name: 7 GEP Clinic, Prague, CZ 130 00, Czech Republic
Author_xml – sequence: 1
  fullname: Drastich, Pavel
– sequence: 2
  fullname: Spicak, Julius
– sequence: 3
  fullname: Buckova, Barbora
– sequence: 4
  fullname: Ngo, Ondrej
– sequence: 5
  fullname: Suchanek, Stepan
– sequence: 6
  fullname: Vojtechova, Gabriela
– sequence: 7
  fullname: Benes, Marek
– sequence: 8
  fullname: Tachecí, Ilja
– sequence: 9
  fullname: Martinek, Jan
– sequence: 10
  fullname: Majek, Ondrej
– sequence: 11
  fullname: Grega, Tomas
– sequence: 12
  fullname: Zavoral, Miroslav
– sequence: 13
  fullname: Voska, Michal
– sequence: 14
  fullname: Bures, Jan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31565052$$D View this record in MEDLINE/PubMed
BookMark eNqFkttrFDEUxgep2Iu--SwDvgi6bTK5zbwIy1p1oSh4Ad9CNjnZZplNtslMZf3rzXS2rVsUmYcMJ7_vO-eE77g48MFDUTzH6BRjxs4qhJsz1ghGSf2oOMK8FhNO0I-D239c4cPiOKUVQrxCiD0pDglmnCFWHRW_plr3UeltGWw5C23w5UxtUt9Cee5NSDpstqUN8eYugu5UW36CsGlVcqp8B10uuSxyvpx7466d6VWbyi9gIUYwN1JVftURwDu_HFuMtk-Lxzaz8Gx3nhTf359_m32cXHz-MJ9NLyaaC9RNlOW11QIb2xCDwCIN1BoAi5ngmDKMqK7FAhgzFAkORDQGY9pgmqti0ZCTYj76mqBWchPdWsWtDMrJm0KIS6li53QLklCLOAG6MEZTLOq6WmiiCRiMKltjlb3ejl6bfrEGo8F3UbV7pvs33l3KZbiWXORJKc0Gr3YGMVz1kDq5dklD2yoPoU-yqpqGUkHrAX35AF2FPvr8VAOFhKgwYffUUuUFnLch99WDqZxyxDChmA_U6V-o_BlYO50DZV2u7wle_Lno3Ya3ycnAmxHQMaQUwd4hGMkhmHIIptwFM-PVA1y7Tg3RyYO49l-i16Po0nmjfrr_tdiNDJkBq-7pjFYNJr8BkkP7UA
CitedBy_id crossref_primary_10_3390_cancers12040890
crossref_primary_10_3390_jcm9061648
crossref_primary_10_1007_s10620_023_08133_7
crossref_primary_10_1097_MOG_0000000000000688
crossref_primary_10_1080_14737140_2023_2207828
crossref_primary_10_1016_j_hoc_2022_02_001
crossref_primary_10_1016_j_gie_2023_09_002
crossref_primary_10_1016_j_pbiomolbio_2022_09_003
crossref_primary_10_1055_a_1249_3938
crossref_primary_10_1177_09691413221074803
crossref_primary_10_1016_j_giec_2020_02_009
crossref_primary_10_1055_a_1529_5814
crossref_primary_10_1055_a_1353_4849
crossref_primary_10_13105_wjma_v12_i4_100726
crossref_primary_10_3389_fgstr_2023_1316334
crossref_primary_10_1055_a_1401_9528
crossref_primary_10_1080_14737159_2022_2065197
crossref_primary_10_1109_ACCESS_2021_3136796
crossref_primary_10_1111_den_13769
crossref_primary_10_1055_a_1308_1297
crossref_primary_10_1097_MEG_0000000000002809
crossref_primary_10_1001_jama_2021_4417
crossref_primary_10_1186_s12876_021_02081_0
crossref_primary_10_7759_cureus_17560
crossref_primary_10_3390_diagnostics12092093
crossref_primary_10_1038_s41575_022_00612_y
crossref_primary_10_11569_wcjd_v29_i4_210
crossref_primary_10_4251_wjgo_v16_i4_1119
crossref_primary_10_1177_09691413221109999
Cites_doi 10.1097/MEG.0000000000001090
10.1097/MCG.0b013e3181dac04b
10.3748/wjg.v20.i14.3825
10.1097/CEJ.0b013e328364f203
10.1186/1471-230X-12-80
10.1016/S0889-8553(05)70283-1
10.1055/s-0031-1291717
10.1056/NEJMoa0907667
10.1200/JCO.2005.05.2308
10.1016/S0140-6736(10)60551-X
10.1038/35013140
10.1053/j.gastro.2015.01.025
10.1053/j.gastro.2008.03.040
10.1056/NEJM199305133281901
10.1056/NEJMoa0806347
10.1055/s-0039-1681553
10.1055/s-0032-1325997
10.1111/codi.13965
10.1055/s-0034-1365402
ContentType Journal Article
Copyright Copyright © 2019 Michal Voska et al.
COPYRIGHT 2019 John Wiley & Sons, Inc.
Copyright © 2019 Michal Voska et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0
Copyright © 2019 Michal Voska et al. 2019
Copyright_xml – notice: Copyright © 2019 Michal Voska et al.
– notice: COPYRIGHT 2019 John Wiley & Sons, Inc.
– notice: Copyright © 2019 Michal Voska et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. http://creativecommons.org/licenses/by/4.0
– notice: Copyright © 2019 Michal Voska et al. 2019
DBID ADJCN
AHFXO
RHU
RHW
RHX
AAYXX
CITATION
NPM
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.1155/2019/5975438
DatabaseName الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
ProQuest Central Student
ProQuest Research Library
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed


CrossRef
MEDLINE - Academic
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1687-630X
Editor Riccioni, Maria Elena
Editor_xml – sequence: 1
  givenname: Maria Elena
  surname: Riccioni
  fullname: Riccioni, Maria Elena
EndPage 8
ExternalDocumentID oai_doaj_org_article_34f063e4bddc417882bc3c3ed102f81a
PMC6745144
A605134165
31565052
10_1155_2019_5975438
1155291
Genre Journal Article
GeographicLocations Czech Republic
GeographicLocations_xml – name: Czech Republic
GrantInformation_xml – fundername: Ministerstvo Zdravotnictví Ceské Republiky
  grantid: AZV 16-29614A
GroupedDBID ---
0R~
24P
29H
2WC
4.4
53G
5GY
5VS
8G5
AAFWJ
AAMMB
AAWTL
ABDBF
ABUWG
ACCMX
ACUHS
ADBBV
ADJCN
ADRAZ
AEFGJ
AENEX
AFKRA
AFPKN
AGXDD
AHFXO
AIDQK
AIDYY
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
C1A
CCPQU
CS3
DIK
DWQXO
E3Z
EBD
EBS
EJD
EMOBN
ESX
F5P
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
H13
HYE
IAO
IHR
IL9
ITC
KQ8
M2O
M48
O5R
O5S
OK1
OVT
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PUEGO
RHU
RNS
RPM
TR2
TUS
~8M
3V.
AAJEY
M~E
RHW
RHX
AAYXX
CITATION
NPM
PMFND
7XB
8FK
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c670t-af68fc71df93d0ef0ce4fdeef1576145104c87be55d4076e379d11491487b7b93
IEDL.DBID M48
ISSN 1687-6121
IngestDate Wed Aug 27 01:29:15 EDT 2025
Thu Aug 21 18:33:11 EDT 2025
Fri Sep 05 06:51:05 EDT 2025
Fri Jul 25 21:02:16 EDT 2025
Tue Jun 17 22:03:07 EDT 2025
Tue Jun 10 21:04:43 EDT 2025
Wed Feb 19 02:27:37 EST 2025
Tue Jul 01 04:23:31 EDT 2025
Thu Apr 24 23:00:02 EDT 2025
Sun Jun 02 19:20:15 EDT 2024
Thu Sep 25 15:06:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2019
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/4.0
Copyright © 2019 Michal Voska et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c670t-af68fc71df93d0ef0ce4fdeef1576145104c87be55d4076e379d11491487b7b93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Maria Elena Riccioni
ORCID 0000-0003-3583-2651
0000-0002-7911-470X
0000-0003-3659-0252
0000-0002-5502-0768
0000-0003-0326-117X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2019/5975438
PMID 31565052
PQID 2290772135
PQPubID 2037462
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_34f063e4bddc417882bc3c3ed102f81a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6745144
proquest_miscellaneous_2299447484
proquest_journals_2290772135
gale_infotracmisc_A605134165
gale_infotracacademiconefile_A605134165
pubmed_primary_31565052
crossref_primary_10_1155_2019_5975438
crossref_citationtrail_10_1155_2019_5975438
hindawi_primary_10_1155_2019_5975438
emarefa_primary_1155291
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-00-00
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – year: 2019
  text: 2019-00-00
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: Egypt
– name: New York
PublicationTitle Gastroenterology research and practice
PublicationTitleAlternate Gastroenterol Res Pract
PublicationYear 2019
Publisher Hindawi Publishing Corporation
Hindawi
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: Hindawi Publishing Corporation
– name: Hindawi
– name: John Wiley & Sons, Inc
– name: Wiley
References 11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
10
References_xml – ident: 18
  doi: 10.1097/MEG.0000000000001090
– ident: 6
  doi: 10.1097/MCG.0b013e3181dac04b
– ident: 3
  doi: 10.3748/wjg.v20.i14.3825
– ident: 16
  doi: 10.1097/CEJ.0b013e328364f203
– ident: 17
  doi: 10.1186/1471-230X-12-80
– ident: 2
  doi: 10.1016/S0889-8553(05)70283-1
– ident: 7
  doi: 10.1055/s-0031-1291717
– ident: 11
  doi: 10.1056/NEJMoa0907667
– ident: 1
  doi: 10.1200/JCO.2005.05.2308
– ident: 10
  doi: 10.1016/S0140-6736(10)60551-X
– ident: 5
  doi: 10.1038/35013140
– ident: 15
  doi: 10.1053/j.gastro.2015.01.025
– ident: 9
  doi: 10.1053/j.gastro.2008.03.040
– ident: 8
  doi: 10.1056/NEJM199305133281901
– ident: 12
  doi: 10.1056/NEJMoa0806347
– ident: 19
  doi: 10.1055/s-0039-1681553
– ident: 4
  doi: 10.1055/s-0032-1325997
– ident: 13
  doi: 10.1111/codi.13965
– ident: 14
  doi: 10.1055/s-0034-1365402
SSID ssj0062005
Score 2.290544
Snippet Backround. Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. Aim. To assess the accuracy of second-generation...
Backround . Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. Aim . To assess the accuracy of...
Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. To assess the accuracy of second-generation capsule...
Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening.BACKROUNDCapsule colonoscopy might present an alternative to...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
hindawi
emarefa
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Accuracy
Blood tests
Cancer
Colonoscopy
Colorectal cancer
Diagnosis
Disease prevention
Endoscopy
Feces
Gastroenterology
Internal medicine
Medical screening
Medicine
Oncology, Experimental
Patients
Polyethylene glycol
Polyps
Small intestine
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxsxEBYl0NJLSfrcxi0qpPRQTLReSSsdXTchLSSXNpCb0OpBDGFdHJuQ_PrMaOWtt7Tk0uOutJJHGknzyTPfEHLQKOaiZAGTuwBAmTA3thYMuVg6paJWQXm8hzw9kyfn_PuFuNhK9YU-YR09cDdwhxWPcIoG3njveAmAbdK4ylXBw8kYVZlMI6bZBkx1e7DEuxKEWlJhENyk3Li8CwFov9SHYEYLjjEpW4dR4uxPgbkWnm2_Rz--RHR8M_-bDfqnK-XW2XS8S55lo5JOO2H2yKPQPidPTvPf5i_I3dS59dK6W7qIdAbbXUtnFuDxVaBHrV9gZMotBes1leEWCI2doWs5hljSr2GV_LVaOm_ptz6A65omktpl8OlTS3849OGBo7Dromv2JTk_Pvo5OxnnpAtjJ2u2GtsoVXR16aOuPAuRucCjDyGWgEwwrS_jTtVNEMIDFpShqrUHTKUBVtVN3ejqFdlpF214Q6jkYJ5MYO6YDNx5q5XFz6WoZOOsFwX5vBl94zIjOSbGuDIJmQhhcK5MnquCfOxr_-qYOP5R7wtOZF8H-bPTC9Aqk7XKPKRVBXmd1eB3X0hWp8uCfEK1MLj-4cc6m8MYQGRk0jJTwIdIkidBvNGgJqxbNyg-yIr1gDijjdaZvL1cGyTpB1hUVtDKh74YO0CXuTYs1qmO5hypYkGYTkn7jipA7ZjBsCD1QH0HgzYsaeeXiXxc1qADnL_9H6O8T56iqN2N1ojsrJbr8A5svFXzPi3ne0E7Se0
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA_egeKL-G11lQgnPshiu0nT9HFd71iFuwf1YN9Cmky4haMr-4Gcf70zabbaU9HHNpOvZpLML535hbGjRucuqBzochcEKJPcja1FQy4UTutQa9CeziFPz9T8XH5clItEkrT5_Rc-7nYIz4v6Ldq9pRT6gB1oRcr7ab7YL7iKDkYIVylNEW-TYu_ffi3vYOeJBP0xCtfis-0X5JsXBIW_Lf9kcF73m_xlIzq5y-4kC5JPuyG_x25Ae5_dOk3_yB-w71Pndmvrrvgq8BmubS2fWcTCl8CPW7-iMJQrjqZqTKP1Dgs7Iz9yiqfk72EbnbNavmz5hz5aa8MjI-0afMxq-WdHDju473VVdMU-ZOcnx19m83G6YWHsVJVvxzYoHVxV-FALn0PIHcjgAUKBMITu8M2l01UDZekR-CkQVe0RQNWIoaqmamrxiB22qxaeMK4k2iITAWgggHTe1tpSdlUK1Tjry4y92X994xL9ON2CcWkiDClLQ2Nl0lhl7FUv_bWj3fiL3DsayF6GyLLjC1Qgk-aeETKgIQay8d7JAjH_pHHCCfBoXAVd2Iw9Tmrwsy5ipquLjL0mtTA02bGxzqaYBewy0WaZKYJBYsRT2L3RQBInqRskHyXF-kd3RnutM2kt2Rhi5EcMVAgs5WWfTBWQf1wLq12UqaUkXljsTKekfUUCITpdV5ixaqC-g482TGmXF5FpXFWoA1I-_b_WP2O36bE7oBqxw-16B8_RZNs2L-KE_QE15zb1
  priority: 102
  providerName: Hindawi Publishing
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdGJxAviG8CBRlpiAcUNWlsJ3lAqCudBtIqBEzam-X4g1WaktG1QuOv585xsgXx8djaiXPx-Xw_5-53hOxVRaKdSCwWdwGAMk10rBQ4ci7VReHKwhYGzyGPluLwmH084Sc7ZNnlwmBYZWcTvaE2jcYz8gnykoMnmGb83fn3GKtG4dfVroSGCqUVzFtPMXaD7IJJ5smI7O4vlp8-d7ZZ4BkKQjBRYHLcNO1C4TmfwE5YTsC95gxzVa5tUp7L3yfsKvitett98xRR84_Vn3zT30Msr-1ZB3fJneBs0lmrHffIjq3vk1tH4XP6A_JzpvV2rfQlbRydgxms6VwBbD6zdFGbBjNWLil4tb4NTSPcbIkh55h6Sd_bjY_jqumqph_6xK4L6slr19b4SxX9ojG2B7bIdoj2tg_J8cHi6_wwDsUYYi3yZBMrJwqn89S4MjOJdYm2zBlrXQqIBcv9JkwXeWU5N4ARhc3y0gDWKgFu5VVeldkjMqqb2j4hVDBwW6aZBV_CMm1UWSi8XPBMVFoZHpE33duXOjCVY8GMM-kRC-cS50qGuYrIq773ecvQ8Zd--ziRfR_k1fZ_NOtvMixTmTEHPptllTGapTnAj0pnOrMG_DBXpCoij4MaXI2FJHZlGpHXqBYS7QI8rFYhvQFERoYtOQPciOR5AsQbD3rCetaD5r2gWP8RZ9xpnQxm50JeLZKIvOybcQAMpatts_V9SsaQQhaEaZW0HygDNI-VDSOSD9R38NKGLfXq1JOSixx0gLGn_36sZ-Q2CtGeYY3JaLPe2ufg1W2qF2Gp_gJ5hEeW
  priority: 102
  providerName: ProQuest
Title Accuracy of Colon Capsule Endoscopy for Colorectal Neoplasia Detection in Individuals Referred for a Screening Colonoscopy
URI https://search.emarefa.net/detail/BIM-1155291
https://dx.doi.org/10.1155/2019/5975438
https://www.ncbi.nlm.nih.gov/pubmed/31565052
https://www.proquest.com/docview/2290772135
https://www.proquest.com/docview/2299447484
https://pubmed.ncbi.nlm.nih.gov/PMC6745144
https://doaj.org/article/34f063e4bddc417882bc3c3ed102f81a
Volume 2019
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbGJhAviDuBUhlpiAdUltSO4zwg1JWOgrQKDSr1LXJ8YZWqBLJWUH495zhpINMQvERKfIvtc-zz2edCyGEuQ-1EaDG4CwCUYagHSoEg5yItpUullQbPIU9nYjrnHxbxYo_soo02A3hxJbTDeFLzavXqx7ftG2D4157h4xjwe5QegWAccyavkQN_U4RKfLy9TxB4doLQS0g0ihtGOxX4S6U7m5P34e8NdRW8q3bNvn6OaPn78iqZ9LJq5R971cltcqsRMumopoo7ZM8Wd8mN0-Ya_R75OdJ6Uym9paWjY1j-CjpWAJdXlk4KU6KlypaCNOvTcEmEymaoao4ml_StXXv9rYIuC_q-Nei6oN5pbWWNL6roJ406PbA11k3U1d4n85PJ5_F00ARhGGiRhOuBckI6nUTGpcyE1oXacmesdREgFQzzG3Itk9zGsQFsKCxLUgMYKwWYleRJnrIHZL8oC_uIUMFBXBkyCzKE5dqoVCosLmImcq1MHJCXu9HPdOOhHANlrDKPVOI4w7nKmrkKyPM299faM8df8h3jRLZ50J-2_1BWX7KGPTPGHchqlufGaB4lADtyzTSzBuQvJyMVkIcNGfxuC53XpVFAXiBZZEih8LNaNWYN0GX0rJWNAC-i0zwB3et1cgIf607yYUNY_-hOb0d12Y5bMnTaDzApYlDLszYZG0AVusKWG58n5Rxdx0JnaiJtG2KA4jGiYUCSDvl2Bq2bUizPvTNykQANcP74v4fhCbmJ_amPsXpkf11t7FMQ7NZ5nxwcT2Yfz_r-YASe7xZR3_MxPM-mi1-qZEuF
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JbtswECUCB10uRfe6TVsWSNBDYVgLSUmHoHAcB3YTG0WbALkpFJfGQCClXhC4H9dv64xEKXHR5ZSjREoUxdHMG2rmDSHbWewpKzyDxV3AQQk81ZESgJz1VRzbJDaxxn3I8UQMT9inU366QX7WuTAYVlnrxFJR60LhHnkXeckBCfoh_3j5vYNVo_Dval1CQ7rSCnq3pBhziR2HZnUFLtx8d7QP670TBAeD4_6w46oMdJSIvEVHWhFbFfnaJqH2jPWUYVYbY32A4ljH1mMqjjLDuQbnR5gwSjQ4EQn4EVEWZUjGBCZgk-EGSots7g0mn7_UtkDgng26fCLGZLzAr0PvOe-C5U26AOc5w9yYG0axrB1QJghLOJaNrbhzjl761fRPWPj3kM4bNvLgIXngwC3tVdL4iGyY_DG5O3a_75-QHz2lljOpVrSwtA9qN6d9CW76haGDXBeYIbOigKLLNlTFcLMJhrhjqifdN4sybiyn05yOmkSyOS3JcmdGl5dK-lVhLBGY5GqI6rZPycmtLMsz0sqL3LwgVDCASUFoALsYprRMYomXCx6KTEnN2-RD_fZT5ZjRsUDHRVp6SJynuFapW6s22Wl6X1aMIH_pt4cL2fRBHu_yRDH7ljq1kIbMAkY0LNNaMT8CdydToQqNBtxnY1-2yXMnBtdjIWle4rfJexSLFPUQPKySLp0CpoyMXmkP_FQk6xMwva21nqA_1FrzthOs_0xnq5a61Km5eXr9UbbJu6YZB8DQvdwUy7JPwhhS1sJkKiFtBgp98Cc8HrRJtCa-ay9tvSWfnpck6CICGWDs5b8f6y25NzweH6VHo8nhK3IfJ1Ttn22R1mK2NK8BUS6yN-6zpeTstjXFL8amhHk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTUy8IO4EChhpEw-oai6OkzxMqOtarYxVEzBpb8HxhVWaktGLpvIT-VWc4zjZirg87TGxE8fxyTnf55wLITtF6kvDfY3FXYCghL7sCgFAzgQyTU2W6lThPuTxhB-esg9n8dkG-dnEwqBbZaMTraJWlcQ98h7mJQckGERxzzi3iJOD0fvL712sIIV_WptyGsKVWVB7Nt2YC_I40qsroHPzvfEBrP1uGI6GXwaHXVdxoCt54i-6wvDUyCRQJouUr40vNTNKaxMALMeatj6TaVLoOFZAhLiOkkwBociAUyRFUmBiJjAHWwlYfSCCW_vDycmnxi5w3L9B-sdTDMwLg8YNP457YIWzHkD7mGGczA0DaesI2GBhAceitRt3zpGxX03_hIt_d--8YS9H98k9B3Rpv5bMB2RDlw_J9rH7lf-I_OhLuZwJuaKVoQNQwSUdCKDsF5oOS1VhtMyKAqK2baiW4WYTdHfHsE96oBfWh6yk05KO26CyObWJc2da2UsF_SzRrwjMcz1EfdvH5PRWluUJ2SyrUj8jlDOATGGkAcdoJpXIUoGX8zjihRQq9si75u3n0mVJx2IdF7llS3Gc41rlbq08stv2vqyzg_yl3z4uZNsHc3rbE9XsW-5URB4xA3hRs0IpyYIEqE8hIxlpBRjQpIHwyFMnBtdjYQK9LPDIWxSLHHUSPKwULrQCpozZvfI-cFZM3Mdhep21nqBL5FrzjhOs_0yn00hd7lTePL_-QD3ypm3GAdCNr9TV0vbJGMP0tTCZWkjbgaIAuIUfhx5J1sR37aWtt5TTc5sQnScgA4w9__djvSbboDHyj-PJ0QtyF-dTb6V1yOZittQvAVwuilfuq6Xk620ril9_Aoi9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accuracy+of+Colon+Capsule+Endoscopy+for+Colorectal+Neoplasia+Detection+in+Individuals+Referred+for+a+Screening+Colonoscopy&rft.jtitle=Gastroenterology+research+and+practice&rft.au=Voska%2C+Michal&rft.au=Zavoral%2C+Miroslav&rft.au=Grega%2C+Tomas&rft.au=Majek%2C+Ondrej&rft.date=2019&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1687-6121&rft.volume=2019&rft_id=info:doi/10.1155%2F2019%2F5975438&rft.externalDocID=A605134165
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1687-6121&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1687-6121&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1687-6121&client=summon